000278562 001__ 278562
000278562 005__ 20250525001315.0
000278562 0247_ $$2doi$$a10.1038/s41531-025-00974-5
000278562 0247_ $$2pmid$$apmid:40325017
000278562 0247_ $$2pmc$$apmc:PMC12052990
000278562 0247_ $$2altmetric$$aaltmetric:176826415
000278562 037__ $$aDZNE-2025-00595
000278562 041__ $$aEnglish
000278562 082__ $$a610
000278562 1001_ $$aGuidetti, Matteo$$b0
000278562 245__ $$aWill adaptive deep brain stimulation for Parkinson's disease become a real option soon? A Delphi consensus study.
000278562 260__ $$a[London]$$bSpringer Nature$$c2025
000278562 3367_ $$2DRIVER$$aarticle
000278562 3367_ $$2DataCite$$aOutput Types/Journal article
000278562 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1747918573_22615
000278562 3367_ $$2BibTeX$$aARTICLE
000278562 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000278562 3367_ $$00$$2EndNote$$aJournal Article
000278562 520__ $$aWhile conventional deep brain stimulation (cDBS) treatment delivers continuous electrical stimuli, new adaptive DBS (aDBS) technology provides dynamic symptom-related stimulation. Research data are promising, and devices are already available, but are we ready for it? We asked leading DBS experts worldwide (n = 21) to discuss a research agenda for aDBS research in the near future to allow full adoption. A 5-point Likert scale questionnaire, along with a Delphi method, was employed. In the next 10 years, aDBS will be clinical routine, but research is needed to define which patients would benefit more from the treatment; second, implantation and programming procedures should be simplified to allow actual generalized adoption; third, new adaptive algorithms, and the integration of aDBS paradigm with new technologies, will improve control of more complex symptoms. Since the next years will be crucial for aDBS implementation, the research should focus on improving precision and making programming procedures more accessible.
000278562 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000278562 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000278562 7001_ $$aBocci, Tommaso$$b1
000278562 7001_ $$aDe Pedro Del Álamo, Marta$$b2
000278562 7001_ $$aDeuschl, Guenther$$b3
000278562 7001_ $$aFasano, Alfonso$$b4
000278562 7001_ $$aMartinez-Fernandez, Raul$$b5
000278562 7001_ $$aGasca-Salas, Carmen$$b6
000278562 7001_ $$aHamani, Clement$$b7
000278562 7001_ $$aKrauss, Joachim K$$b8
000278562 7001_ $$0P:(DE-2719)2811089$$aKühn, Andrea A$$b9$$udzne
000278562 7001_ $$aLimousin, Patricia$$b10
000278562 7001_ $$aLittle, Simon$$b11
000278562 7001_ $$aLozano, Andres M$$b12
000278562 7001_ $$aMaiorana, Natale V$$b13
000278562 7001_ $$aMarceglia, Sara$$b14
000278562 7001_ $$aOkun, Michael S$$b15
000278562 7001_ $$aOliveri, Serena$$b16
000278562 7001_ $$aOstrem, Jill L$$b17
000278562 7001_ $$aScelzo, Emma$$b18
000278562 7001_ $$aSchnitzler, Alfons$$b19
000278562 7001_ $$aStarr, Philip A$$b20
000278562 7001_ $$aTemel, Yasin$$b21
000278562 7001_ $$aTimmermann, Lars$$b22
000278562 7001_ $$aTinkhauser, Gerd$$b23
000278562 7001_ $$aVisser-Vandewalle, Veerle$$b24
000278562 7001_ $$aVolkmann, Jens$$b25
000278562 7001_ $$aPriori, Alberto$$b26
000278562 773__ $$0PERI:(DE-600)2819218-7$$a10.1038/s41531-025-00974-5$$gVol. 11, no. 1, p. 110$$n1$$p110$$tnpj Parkinson's Disease$$v11$$x2373-8057$$y2025
000278562 8564_ $$uhttps://pub.dzne.de/record/278562/files/DZNE-2025-00595%20SUP.pdf
000278562 8564_ $$uhttps://pub.dzne.de/record/278562/files/DZNE-2025-00595.pdf$$yOpenAccess
000278562 8564_ $$uhttps://pub.dzne.de/record/278562/files/DZNE-2025-00595%20SUP.pdf?subformat=pdfa$$xpdfa
000278562 8564_ $$uhttps://pub.dzne.de/record/278562/files/DZNE-2025-00595.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000278562 909CO $$ooai:pub.dzne.de:278562$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000278562 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811089$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000278562 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000278562 9141_ $$y2025
000278562 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-11
000278562 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000278562 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:43:48Z
000278562 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:43:48Z
000278562 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000278562 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:43:48Z
000278562 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PARKINSONS DIS : 2022$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000278562 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000278562 9201_ $$0I:(DE-2719)5000008$$kAG Kühn$$lMovement Disorders (Parkinson's disease, Dystonia)$$x0
000278562 980__ $$ajournal
000278562 980__ $$aVDB
000278562 980__ $$aUNRESTRICTED
000278562 980__ $$aI:(DE-2719)5000008
000278562 9801_ $$aFullTexts